• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Abnormal menstruation may be associated with worse cardiometabolic outcomes later in life

bySoroush NedaieandAlex Chan
April 19, 2023
in Cardiology, Chronic Disease, Endocrinology, Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this large retrospective matched cohort study of women aged 18-40 years, a history of abnormal menstruation was associated with an increased risk of cardiometabolic outcomes in later life

Evidence Rating Level: 2 (Good)

According to estimates from the global burden of disease study, cardiovascular disease (CVD) is the leading cause of mortality in women accounting for 35% of total deaths worldwide. Menstrual cycle history and its link to CVD are not mentioned in recent literature reviews and consensus statements, which support the association between female reproductive factors and the risk of CVD in later life. Long or irregular menstrual cycles are associated with cardiovascular risk factors including hyperinsulinemia, dyslipidemia, hypertension, and diabetes mellitus. Its management has predominantly focused on addressing infertility implications, leaving other potential longer-term risks such as CVD underappreciated. This retrospective cohort study utilizes electronic health data from UK primary care to investigate the association between menstrual cycle characteristics and long-term risk of cardiometabolic outcomes. From the study population of women aged 18-40 years two cohorts were created and matched to controls — one composed of 215,378 women with a history of irregular or absent menstrual cycles and the other composed of 36,947 women with infrequent or frequent menstrual cycles. Comparing women with irregular menstrual cycles to those with regular menstrual cycles the hazard ratio for composite CVD was 1.08 (95% CI 1.00–1.19; p = 0.062). Comparing infrequent or frequent menstruation to menstrual cycles of normal frequency, a hazard ratio for composite CVD of 1.24 (95% CI 1.02–1.52; p = 0.031) was observed. Both irregular menstrual cycles and frequent or infrequent cycles were linked with an increased risk of hypertension and type 2 diabetes mellitus. Overall, these findings suggest that a history of irregular, frequent, or infrequent menstrual cycles is associated with an increased risk of cardiometabolic outcomes later in life. This opens up an avenue to apply menstrual history as a screening tool to identify and periodically assess individuals at a higher risk of poor future cardiometabolic health.

Click to read the study in BMC Medicine

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

Food compounds associated with disease activity in inflammatory bowel disease 

2 Minute Medicine Rewind June 23, 2025

Tags: cardiovascular diseasechronic diseasegynecologymenstruation
Previous Post

Past infection with pre-omicron variants of COVID-19 protects against re-infection

Next Post

Spirituality may help patients with weight management after bariatric surgery

RelatedReports

Chronic Disease

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

June 27, 2025
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Food compounds associated with disease activity in inflammatory bowel disease 

June 25, 2025
Weekly Rewinds

2 Minute Medicine Rewind June 23, 2025

June 23, 2025
Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines
Cardiology

Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms

June 19, 2025
Next Post
Increasing maternal BMI linked to higher risk of cerebral palsy

Spirituality may help patients with weight management after bariatric surgery

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients

Pimecrolimus effective first-line treatment for atopic dermatitis

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early acetaminophen use reduces mortality risk in patients with sepsis-associated encephalopathy
  • Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
  • 2 Minute Medicine Rewind June 30, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.